Product Search
We provide safer and differentiated healthcare products to customers
by combining medical technologies.
PRODUCT
LEVOCID TAB
Print
product information
LEVOCID TAB
| Classification | Ethical the Counter(ETC) |
|---|---|
| Major Ingredients | Levofloxacin hydrate |
| Efficacy/Effectiveness | Staphylococcus aureus, Enterobacter, Serratia, Proteus, Pseudomonas, Haemophilus influenzae |
| Appearance | White or light yellow circular film retreat |
product information
Information
1) Ingredients and content (per gram)
- Levofloxacin hydrate ---------------------------------- 100mg
2) Usage and dosage
(100 mg tablets)
○ Regular adult levofloxacin 100 mg once orally two or three times a day is given orally. Patients with severe or inadequate efficacy should be administered 200 mg once a day, three times a day.
Age, and symptoms.
3) Storage
- Airtight container, storage at room temperature (1-30 ℃)
4) Packing unit
- 30, 500 tablets
5) Period
- 36 months from date of manufacture
Details
1. Warning
1) Patients who received quinolone antibiotics, such as levofloxacin, reported a tendon rupture such as shoulder, hand, or Achilles tendon which required surgical operation or prolonged the period of disability. In postmarketing surveys, this risk is higher in older adults or in combination with steroids. If the patient experiences pain, inflammation, or rupture of the tendon, administration of this drug should be discontinued. You should rest and refrain from exercising until you are clearly diagnosed as not having a tendonitis or tendon rupture. Tear rupture may occur during or after administration of this drug.
2) Quinolone antimicrobial agents have neuromuscular blocking action, which can lead to more severe symptoms in patients with severe workforce. Post-marketing surveillance has reported serious adverse reactions in patients with severe work-force taking quinolone antibiotics, including those requiring death and a respiratory aid. (See "3. PRECAUTIONS")
1) Patients who received quinolone antibiotics, such as levofloxacin, reported a tendon rupture such as shoulder, hand, or Achilles tendon which required surgical operation or prolonged the period of disability. In postmarketing surveys, this risk is higher in older adults or in combination with steroids. If the patient experiences pain, inflammation, or rupture of the tendon, administration of this drug should be discontinued. You should rest and refrain from exercising until you are clearly diagnosed as not having a tendonitis or tendon rupture. Tear rupture may occur during or after administration of this drug.
2) Quinolone antimicrobial agents have neuromuscular blocking action, which can lead to more severe symptoms in patients with severe workforce. Post-marketing surveillance has reported serious adverse reactions in patients with severe work-force taking quinolone antibiotics, including those requiring death and a respiratory aid. (See "3. PRECAUTIONS")